Issues regarding FDA animal drug approval process.
2025 · 3rd Quarter (July 1 - Sep 30)
BOEHRINGER INGELHEIM ANIMAL HEALTH US
Filed by CAPITOL COUNSEL LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 16, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- CAPITOL COUNSEL LLC
- Filing UUID
- 3d953e09-70dc-4584-af97-d3d50e5f5cd9
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues regarding FDA animal drug approval process.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.